IP Library Granted Patent US 10,656,166
Granted Patent B2
US 10,656,166 · App. 15/870,822 · Granted May 19, 2020

Inhibiting chronic blood and nephrological disorders using lysine-based supplements

Inventor: John Burd (San Diego, CA)
Assignee: Lysulin, Inc.
G01N33/70A23L33/15A23L33/16A23L33/175A61K47/645G01N33/66G01N33/6896G01N2800/347G01N2800/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,656,166
App. No.
15/870,822
Granted
May 19, 2020
Kind
B2
Abstract

A method of affecting blood chemistry using a supplement may comprise: measuring a blood glucose level; determining a blood glucose level; and if the blood glucose level exceeds a threshold, administering a supplement comprising lysine, zinc, and vitamin C.

Claims (20)

1. A method of monitoring blood glucose levels, the method comprising:

measuring a current blood glucose level of an individual from a biochemistry test;

determining the current blood glucose level; and

administering a supplement to the individual consisting of lysine, zinc, and vitamin C.

2. The method of claim 1 , wherein the test comprises a fingerprick test that quantitatively indicates the current blood glucose level.

3. The method of claim 1 , further comprising displaying, on a graphical user interface, the current blood glucose level.

4. The method of claim 1 , wherein the test comprises a fingerprick test that uses visual cues to indicate the current blood glucose level.

5. The method of claim 1 , further comprising:

measuring a second blood glucose level after administering the supplement; and

administering a second dose of the supplement comprising lysine, zinc, and vitamin C to reduce the second blood glucose level.

6. The method of claim 1 , wherein the supplement consists of a range of about 500 mg to about 3000 mg of lysine.

7. The method of claim 1 , wherein the supplement consists of less than about 200 mg of zinc.

8. The method of claim 1 , wherein the supplement consists of a range of about 50 mg to about 500 mg of vitamin C.

9. The method of claim 1 , wherein the supplement consists of a range of about 500 mg to about 3000 mg of lysine, a range of less than about 200 mg of zinc, and a range of about 50 mg to about 500 mg vitamin C.

10. The method of claim 1 , wherein a lysine portion of the supplement comprises D-lysine.

11. The method of claim 1 , wherein a lysine portion of the supplement comprises L-lysine.

12. The method of claim 1 , further comprising:

measuring a current HbA1c level of an individual from the biochemistry test;

determining the current HbA1c level; and

administering the supplement to the individual comprising lysine, zinc, and vitamin C to reduce the current HbA1c level.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 16, 2019
From: BURD, JOHN
To: LYSULIN, INC.
Reel/Frame 049205/0005 →
Continuity (4)
Continuation 15870813 · Jan 12, 2018
Continuation In Part 15817574 · Nov 20, 2017
Provisional Application 62581573 · Nov 3, 2017
Related Publication 20190137519A1 · May 9, 2019